| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/17/2007 | US20070110800 Pharmaceutical composition having uniform drug distribution and potency |
| 05/17/2007 | US20070110798 Liposomes useful for drug delivery to the brain |
| 05/17/2007 | US20070110797 Methods and Compositions For Topical Wound Treatment |
| 05/17/2007 | US20070110796 Devices and methods for reducing scar tissue formation |
| 05/17/2007 | US20070110795 Biocompatible; thin flexible film or porous membrane; topical applying to injuried organ; mixture of chtiosan and an acid |
| 05/17/2007 | US20070110794 Delivery system for topical medications |
| 05/17/2007 | US20070110789 Isoflavone compositions for reducing accumulation of body fat in male mammals, and methods for their use |
| 05/17/2007 | US20070110785 Medical devices with proteasome inhibitors for the treatment of restenosis |
| 05/17/2007 | US20070110782 L-histidine in ophthalmic solutions |
| 05/17/2007 | US20070110775 Phospholipid gel compositions for delivery of aptamers and methods of treating conditions using same |
| 05/17/2007 | US20070110770 combination of apolipoprotein E and an antigenic lipid administered to a subject for the purpose of inducing an immune response against the lipid and in immunization protocols |
| 05/17/2007 | US20070110758 Method for inhibiting bacterial colonisation |
| 05/17/2007 | US20070110751 Compositions and methods for reducing infarct size |
| 05/17/2007 | US20070110740 Composition and methods for tissue preservation |
| 05/17/2007 | US20070110739 Wipe away pain |
| 05/17/2007 | US20070110731 Integument Cell Regeneration Formulation |
| 05/17/2007 | US20070110719 Novel use of adenoviruses and nucleic acids that code for said viruses |
| 05/17/2007 | US20070110716 Relationship of a specific metabolite to insulin resistance |
| 05/17/2007 | US20070110715 Treatment of alzheimer's disease |
| 05/17/2007 | US20070110714 Medicinal composition for treatment of chronic hepatitis c |
| 05/17/2007 | US20070110709 Water-soluble stabilized self-assembled polyelectrolytes |
| 05/17/2007 | US20070110708 Silicon compounds and their use |
| 05/17/2007 | US20070110707 Method of treating diseases involving non-enzymatic glycation |
| 05/17/2007 | US20070110706 Treatment of hyperphosphatemia using crosslinked small molecule amine polymers |
| 05/17/2007 | US20070110704 Combination of 2,3-dibenzylbutyrolactone and licochalcone-a |
| 05/17/2007 | US20070110701 Acyloxyacetic acid polymer and process for producing the same |
| 05/17/2007 | US20070110698 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 05/17/2007 | US20070110685 Combination therapy for the treatment of immunoinflammatory disorders |
| 05/17/2007 | US20070110680 Methods and compositions for controlling biofilm development |
| 05/17/2007 | US20070110678 Method for administration of tiotropium |
| 05/17/2007 | US20070110677 Delivery of drugs to mucosal surfaces |
| 05/17/2007 | US20070110676 Compositions useful for prevention and treatment of common cold and influenza-like symptoms |
| 05/16/2007 | EP1785492A2 Process for preparing docosahexaenoic acid and docosapentaenoic acid |
| 05/16/2007 | EP1785484A1 Oligonucleotide inhibiting tumor cell proliferation and method therefor |
| 05/16/2007 | EP1785430A1 Rapamycin carbohydrate derivatives |
| 05/16/2007 | EP1785426A1 Novel carbapenem compound |
| 05/16/2007 | EP1785425A2 Novel 1,4-diazabicycloalkane derivatives, their preparation and use |
| 05/16/2007 | EP1785424A2 Fused 1,2,4-triazoles and pharmaceutical uses thereof |
| 05/16/2007 | EP1785423A1 Pyridopyrazine derivatives and their use as kinase modulators |
| 05/16/2007 | EP1785422A1 Micronised crystalline tiotropium bromide |
| 05/16/2007 | EP1785421A1 Tropan compound |
| 05/16/2007 | EP1785420A1 Thiazole analogues and uses thereof |
| 05/16/2007 | EP1785418A1 Pyrazole derivative |
| 05/16/2007 | EP1785417A2 Novel non-psychotropic cannabinoids |
| 05/16/2007 | EP1785416A2 9, 10-alpha, alpha-OH-Taxane Analogs and methods for production thereof |
| 05/16/2007 | EP1785415A1 Piperidine derivative or pharmaceutically acceptable salt thereof |
| 05/16/2007 | EP1785156A1 Pharmaceutical compositions |
| 05/16/2007 | EP1785145A1 Transnasal composition having immediate action and high absorbability |
| 05/16/2007 | EP1785144A2 Combinations of bile acids sequestrant(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
| 05/16/2007 | EP1785140A1 Composition and kit for the treatment of urinary disorders |
| 05/16/2007 | EP1785139A1 Antagonist against tolerance to anticancer drugs |
| 05/16/2007 | EP1785138A1 Mitochondria activators |
| 05/16/2007 | EP1785137A1 Remedy for hyperlipemia |
| 05/16/2007 | EP1785136A2 Inhalation medicaments containing an anticholinesterase drug in conjunction with corticosteroid and betamimetic drugs |
| 05/16/2007 | EP1785135A1 New stabilized galenic formulations comprising lansoprazole and their preparation |
| 05/16/2007 | EP1785134A2 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging |
| 05/16/2007 | EP1785133A1 Use of fenofibrate or a derivative thereof for preventing diabetic retinopathy |
| 05/16/2007 | EP1785132A1 Constitutional function-improving agents |
| 05/16/2007 | EP1785131A1 External preparation of s/o type |
| 05/16/2007 | EP1784504A2 Oatp-c gene c463a polymorphism underlies variable response of statin therapy |
| 05/16/2007 | EP1784498A2 Systems and methods for inhibiting metastasis |
| 05/16/2007 | EP1784482A2 Transgenic mammals and cell lines for the identification of glutamate transporter modulators |
| 05/16/2007 | EP1784410A2 Antibacterial agents |
| 05/16/2007 | EP1784409A2 Substituted thienopyrrole carboxylic acid amides, pyrrolothiazole carboxylic acid amides, and related analogs as inhibitors of casein kinase i epsilon |
| 05/16/2007 | EP1784408A1 Triazolobenzodiazepines and their use as vasopressin antagonists |
| 05/16/2007 | EP1784407A1 2-arylmethylazetidine carbapenem derivatives and preparation thereof |
| 05/16/2007 | EP1784406A1 Dihydropteridinones, process for their preparation and their use as drugs |
| 05/16/2007 | EP1784404A1 Pyrrolo[2,3-c]pyridine derivatives and processes for the preparation thereof |
| 05/16/2007 | EP1784403A1 Pyrrolo[3,2-b]pyridine derivatives and processes for the preparation thereof |
| 05/16/2007 | EP1784401A1 Urea derivatives as calcium channel blockers |
| 05/16/2007 | EP1784400A1 Histamine h3 receptor agents, preparation and therapeutic uses |
| 05/16/2007 | EP1784399A2 Pyrimidine derivatives |
| 05/16/2007 | EP1784397A1 5-(1,1'-biphenyl)-4-yl-5-(4-(4-aminoacylphenyl)-piperazin)-1-yl-pyrimidine-2,4,6-trione derivatives, as inhibitors of zinc metallondopeptidases, their preparation and use |
| 05/16/2007 | EP1784396A2 Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors |
| 05/16/2007 | EP1784394A1 Novel piperidine derivatives as histamine h3 receptor ligands for treatment of depression |
| 05/16/2007 | EP1784393A1 Quinazolines useful as modulators of ion channels |
| 05/16/2007 | EP1784392A2 Pyrimidine derivatives |
| 05/16/2007 | EP1784391A1 Phenanthridine carbonyl phenols as cytokine expression modulators |
| 05/16/2007 | EP1784389A1 Process for atorvastatin calcium amorphous |
| 05/16/2007 | EP1784388A1 Biphenyloxyacetic acid derivatives for the treatment of respiratory disease |
| 05/16/2007 | EP1784386A2 Histone deacetylase inhibitors |
| 05/16/2007 | EP1784381A1 Novel substituted aryloxy alkylamines and their use as monoamine neurotransmitter re-uptake inhibitors |
| 05/16/2007 | EP1784225A2 Biomimetic of evodia rutaecarpa fruit extract for amelioration of inflammation |
| 05/16/2007 | EP1784224A2 Egfr kinase inhibitor combinations for treating respiratory and gastrointestinal disorders |
| 05/16/2007 | EP1784223A2 Composition comprising plant and/or fish oils and non-oxidizable fatty acid entities |
| 05/16/2007 | EP1784222A1 Nutritional composition comprising indigestible oligosaccharides |
| 05/16/2007 | EP1784220A2 Bacterial iron acquisition targets |
| 05/16/2007 | EP1784218A1 Nutricional composition comprising immunoglobulins and oligosaccharides |
| 05/16/2007 | EP1784216A1 S100 protein inhibitors for treating leukemia |
| 05/16/2007 | EP1784206A2 Antimicrobial peptides derived from cap18 |
| 05/16/2007 | EP1784201A2 Physiologically active composition |
| 05/16/2007 | EP1784199A1 Compounds for the treatment of marihuana dependence, withdrawal, and usage |
| 05/16/2007 | EP1784198A2 Topical antiviral therapeutic and prophylactic treatment of adenoviruses and their associated diseases |
| 05/16/2007 | EP1784197A2 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a glucocorticosteroid for treatment of asthma, chronic obstructive pulmonary disease or allergic rhinitis |
| 05/16/2007 | EP1784196A2 Ceramide derivatives as modulators of immunity and autoimmunity |
| 05/16/2007 | EP1784195A1 Pharmaceutical composition comprising galactose, selenium, vitamin e and/or phosphatidyl choline, and pharmaceutical uses of galactose |
| 05/16/2007 | EP1784194A1 Histone deacetylase inhibitors |
| 05/16/2007 | EP1784193A1 Composition and method for treatment and prevention of atherosclerosis |
| 05/16/2007 | EP1784192A2 Vaginal cream compositions, kits thereof and methods of using thereof |
| 05/16/2007 | EP1784191A1 Treatment of psychological and cognitive disorders using a cholesterol-lowering agent in combination with an antidepressant |